Novo Nordisk’s Wegovy made a significant impact on the obesity market when it launched in 2021.
Tirzepatide outpacing Wegovy in the obesity space
January 2, 2025
You may also like
Indices by TradingView
Bank sector is hitting this ‘trifecta,’ set to outperform S&P 500
January 13, 2026
This Earnings Season Is Still All About AI. That Won’t Last.
January 13, 2026
Categories
Indices by TradingView


